JPMorgan plans to price return notes linked to basket of 16 stocks

By Susanna Moon

Chicago, July 9 – JPMorgan Chase & Co. plans to price 0% return notes due July 29, 2015 linked to a basket of 16 stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The underlying companies are Pfizer Inc., Merck & Co., Inc., Sanofi, Bristol-Myers Squibb Co., Walgreen Co., Eli Lilly & Co., Mylan Inc., Perrigo Co. and Zoetis Inc., each with a 6 2/3% weight, and Biogen Idec Inc., Celgene Corp., Valeant Pharmaceuticals International, Inc., Illumina, Inc., Endo Health Solutions Inc., Impax Laboratories, Inc. and Gilead Sciences, Inc., each with a 5 5/7% weight.

For each $1,000 principal amount of notes, the payout at maturity will be par plus the return multiplied by an adjustment factor of 99.75%.

J.P. Morgan Securities LLC is the agent.

The notes will price on July 11 and settle on July 16.

The Cusip number is 48127DSH2.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.